We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A pioneering scheme to provide new antibiotics to NHS patients by offering to pay pharmaceutical companies upfront for their work will start this week.
The Chief Medical Officer has announced funding for projects to help beat antimicrobial resistance (AMR) and achieve global universal health coverage.
Antimicrobial resistance remains a serious threat to the health of people in England, with 178 AMR infections diagnosed each day, according to a PHE report.
…team to provide regulatory scientific support for innovators creating novel antimicrobials and diagnostics as part of a programme led by the Department of Health and Social Care (DHSC) to support the international community in tackling the growing threat of antimicrobial resistance (AMR…
The study aims to learn about antimicrobial resistance in healthy people to inform better ways of tackling antimicrobial resistant infections in different populations.
The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
The UK Health Security Agency (UKHSA) is the new organisation responsible for preparing, preventing and responding to threats to the nation’s health.
Dr Jen Dow, the Cross-Defra AMR Coordinator, talks about progress of the development of the new UK Antimicrobial Resistance National Action Plan (AMR NAP).
The £3.5 million investment will help develop new treatments for gonorrhoea and make them available to low- and middle-income countries.
Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
Advice to the Prime Minister on addressing the global burden of antimicrobial resistance
UK government announces up to £39 million cash injection for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF).
The government has announced its new national action plan on antimicrobial resistance to protect people and animals from the risk of drug-resistant infections.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
Letters to sign up for World Antibiotics Awareness Week (WAAW), European Antibiotic Awareness Day (EAAD) activities and Antibiotic Guardians.
The UK emphasised the importance of One Health National Action Plans and urged the WHO to keep AMR high on the political agenda.
New UKHSA data shows that bloodstream infections dropped in 2020 for the first time since 2016 but remain at a higher level than 6 years ago.
The Subsidy Advice Unit (SAU) has accepted a request for a report from the Department for Energy Security and Net Zero (DESNZ) concerning a proposed subsidy to the National Nuclear Laboratory (NNL) Ltd.
The Keep Antibiotics Working campaign returns, urging people to always take their doctor's, pharmacist's or nurse’s advice on antibiotics.
DHSC will award up to £32 million of capital funding to the NHS, universities and research organisations for research into antimicrobial resistance (AMR).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).